NCOA7 and nonpapillary renal cell carcinoma: Nuclear receptor coactivator 7 (NCOA7) inhibits the MAPK/ERK pathway, regulating EMT and apoptosis and thereby inhibiting ccRCC progression and metastasis (Guo et al., 2023).